Net Cash Provided by (Used in) Operating Activities |
-12.5K |
USD |
-43.9% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
18.8K |
USD |
+59.8% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
11.2M |
shares |
+9.8% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
11.1K |
USD |
+114% |
Q3 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.95K |
USD |
-28.4% |
Q3 2024 |
Q1 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
+24.2% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
11.2K |
USD |
+1.45% |
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
53.3K |
USD |
+1.45% |
Q1 2024 |
Q3 2024 |
Additional Paid in Capital |
104K |
USD |
+91.7% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
Q3 2024 |